Alumni Career Sketches
Carl Alving, M.D. '61
I received an M.D. from the University of Miami School of Medicine in Miami, Florida, followed by 2 years of internship/residency in medicine at Barnes Hospital at Washington University School of Medicine in St. Louis, Missouri. I was then a research post-doc for 2 years in the pharmacology department at Wash U, where starting in 1968 I became one of the original researchers in the field of liposomes (they were invented in 1965). From there I was drafted into the Army in 1970 and assigned as a physician/scientist to the Walter Reed Army Institute of Research (WRAIR), where I have remained to this day (including 30 years active duty). I am currently a GS-15 Department of the Army civilian scientist/department chief/medical officer. I have had only a single job in my life, as a biomedical research scientist for 39 years, but this job has had enormous complexity. Perhaps my career has been somewhat atypical in this respect. Since 2004 I have been chief of the Department of Adjuvant and Adjuvant Research in the Division of Retrovirology at WRAIR working on basic and applied research to develop a prophylactic vaccine to HIV-1. We are part of the U.S. Military HIV Research Program. My research lab is centered only in Rockville, MD, but USMHRP that has headquarters located in my building in Rockville has vaccine testing facilities in numerous sites in Africa, Thailand, and elsewhere.
Robert Ruberg, MD '63
Graduated Haverford 1963, Harvard Medical School 1967. Internship, Residency in Surgery, Residency in Plastic Surgery at Hospital of the University of Pennsylvania. Completed training in 1975 and joined faculty at Ohio State University College of Medicine. Currently Professor of Surgery and Executive Vice Chair, Dept of Surgery, OSU College of Medicine. Clinical practice focuses principally on Pediatric Plastic Surgery (cleft lip, cleft palate, craniofacial anomalies). Served as chair of Executive Curriculum Committee at OSU for 18 years. Now Director of OSU Medical Student Learning Communities. National positions included: President, American Association of Plastic Surgeons; Chair, Residency Review Committee for Plastic Surgery; Vice Chair, American Board of Plastic Surgery. Current activities: Student advising; resident education; faculty career development.
Dr Lee Schacter '66
Educational History: Post-Graduate Fellowships (Laboratory)
1969 to 1970 NIH Postdoctoral Fellow, Brandeis University
1970 to 1971 Helen Hay Whitney Postdoctoral Fellow University of California, San Francisco - Biochemistry
1974 to 1976 NIH Postdoctoral fellow Johns Hopkins School of Medicine Cancer Center, Baltimore, Maryland
Educational History: Post-Graduate Medical
1973 Internship, Baltimore City Hospitals
1976 to 1978 Residency, Cleveland Clinic Foundation
1978 to 1979 Oncology Fellowship, Cleveland Clinic Foundation
2003 to Present Independent drug development consultant - PhaseN Consulting and Adjunct Associate Professor of Medicine, University of Pennsylvania
2005 to 2009 MDS Pharma Services Executive Medical Director, Global Head of Oncology. Responsible for the oncology program world-wide
2001 to 2003 Senior VP Clinical Development Protarga, Inc
2000 to 2001 Global Product Team Physician Astra-Zeneca Pharmaceuticals
1996 to 2000 Associate Director for Clinical Trials, Yale Cancer Center and Clinical Associate Professor of Medicine, Yale School of Medicine
1986 to 1996 Director of Clinical Cancer Research, Bristol-Myers Squibb and Clinical Assistant Professor of Medicine, Yale School of Medicine
1984 to 1986 Associate Director of Clinical Cancer Research Bristol-Myers Squibb and Clinical Assistant Professor of Medicine, Upstate Medical Center
1980 to 1984 Assistant Professor of Medicine, Case-Western Reserve School of Medicine and Assistant Chief of Hematology, VA Medical Center, Cleveland
1979 to 1980 Clinical Associate, The Cleveland Clinic, Cleveland
Dr John Golin '73
After graduating from Haverford, I received a Ph.D in genetics from the University of Chicago and did postdoctoral work at The Institute of Molecular Biology (University of Oregon) and DuPont (Wilmington, Delaware). At DuPont, I became interested in the mechanism of multiple drug resistance, a huge clinical problem in the treatment of cancer and many pathogens. Using yeast as a model organism, my research group cloned the major multidrug transporter Pdr5. I brought this work to The Catholic University of America where I am a professor of Biology. I have a small, but very active lab that typically has several graduate and undergraduate students. Our work consistently receives NIH funding to study the mechanistic features of this transporter. Our laboratory uses a large variety of genetic, bioinformatic, and biochemical tools to understand how the energy of ATP binding and hydrolysis are used by Pdr5 to propel drug transport out of the cell. We have a strong collaboration with the Transport Biochemistry Unit of The Laboratory of Cell Biology, NCI/NIH (Suresh Ambudkar). In addition to teaching undergrauate and graduate students, I advise students, write / review papers and grants and still find time to work at the bench. In my free time, I enjoy spending time with my family and running (a good time to think about experiments-especially ones that are not working well).
Dr Leonard Rabinow '76
B. Sci Haverford 1976 (biology);PhD, Univ. Utah (biology) 1983; Post-doc, Genetics, U.C. Berkeley 1983-1985;
Fellowship, Centre de Genetique Moleculaire, Gif-sur-Yvette France 1985-1986; Post-doc, Biological Laboratories, Harvard University, Cambridge, MA 1986-1990; Asst. Professor, Waksman Institute of Molecular Genetics, Rutgers University, Piscataway, NJ 1991-1995; Asst. Professor, Biochemistry and Molecular Biology, Univ. Nebraska Medical School, Omaha NE 1995-1999; Professor, Biology, Universite de Paris Sud 11, Orsay, France1999-present.
Current research interests: Biological consequences and regulation of signaling by LAMMER protein kinases, using the Drosophila orthologue, DOA, as a model system. Projects underway include characterization of upstream regulation of LAMMER kinase activity by ATM and CHK2 kinases in the control of cell cycle progression and sex determination via effects on alternative splicing, as well as the regulation of apoptosis by DOA activity. Two projects just getting underway (5-09) are: 1) Characterization of hyperaggressive behaviour in DOA mutant flies, and 2) Characterization of the role of DOA kinase in organelle transport along microtubules.
Dr. Mark Russ '76
Following graduation from Haverford in 1976, I attended Hahnemann Medical College (now Drexel University) where I received a superb introduction to Psychiatry. I completed my residency in Psychiatry at Montefiore Medical Center/Albert Einstein College of Medicine in 1984. The first half of my career was spent at the Westchester Division of the New York Hospital, Cornell University Medical College (now New York-Presbyterian Medical Center). As a general adult psychiatrist, I was involved in inpatient clinical work, private practice, resident education and training, and research. My research interests focused on understanding the neurobiological underpinnings of self-injurious behavior ("cutting") in patients with serious personality disorders. In particular, I explored the relationship between pain perception and self-injury in this population.
In 1996, I shifted gears in my career. I became interested in Administrative Psychiatry and moved to the Zucker Hillside Hospital (now part of the North Shore-Long Island Jewish Health System). My current title is Director of the Division of Acute Care Psychiatry. I oversee the clinical operation of 240 inpatient psychiatric beds (Zucker Hillside and North Shore Universitity Hospitals), as well as the the psychiatric emergency services at both institutions. I continue to see patients in private practice and am involved in resident education.
Dr Bruce Jacobson '77
After my Haverford graduation in 1977, I attended Case Western Reserve University School of Medicine (1981). I stayed in Cleveland as a PGY-1 (aka "intern") at Mount Sinai Medical Center and PGY-2 to -5 at University Hospitals of Cleveland in the Department of Ophthalmology. For a number of years I remained as a full-time member of the department teaching medical students and residents in ophthalmology. Since 1990 I have been in the full-time clinical practice of general ophthalmology.
Dr. Joseph Hendrick '79
My work at Haverford in Mel Santer's lab led directly to a prolonged stretch (3 years) as a research assistant to Joan Steitz at Yale University. Once it was clear I was never leaving science, I opted for a PhD (Genetics, Yale University). For my PhD, I worked with Dr. Leon Rosenberg on the molecular biology of protein transport of urea cycle enzymes into liver cell mitochondria. I continued my interest in the cell and molecular biology of protein translation and folding as a postdoc, first with William Wickner on bacterial protein secretion and then with F. Ulrich Hartl on molecular chaperones.
I began working in central nervous system drug discovery in 1996, at the Wallingford, CT site of pharmaceutical giant Bristol-Myers Squibb, where my expertise in protein folding in the cell was put to use in the search for therapies for Alzheimer's Disease (a disease of protein misfolding). For the past six years, I've headed the biochemistry group at a much smaller pharmaceutical company, Intra-Cellular Therapies, Inc.(ITI). At ITI, we are focused on the discovery and development of novel therapeutics for neuropsychiatric and neurodegenerative diseases that are targeted at intracellular signaling pathways found specifically in neurons.
Prof. Laurence Eisenlohr '79
Dr. Eisenlohr received his B.A. in 1979 from Haverford College where his senior research project in biology focused upon slime mold motility. He then attended the University of Pennsylvania's School of Veterinary Medicine, receiving his V.M.D. in 1983. Midway through that program, however, Dr. Eisenlohr began to suspect that the basic research he had been exposed to at Haverford was more exciting to him than veterinary medicine. The area he found particularly interesting was immunology. The immune system faces a considerable challenge: to recognize and destroy countless invaders without harming the host. It is still far from clear how this is accomplished. And so, upon completion of veterinary school, he entered Penn's Graduate Program in Immunology where he carried out research on antigen processing and presentation of influenza virus proteins to helper T cells. Antibodies interact directly with foreign invaders in their complete three dimensional forms. In contrast, T cells recognize and respond to cells within the body that have been infected or that have taken up foreign proteins. This occurs because infected cells digest some of the proteins of the invader, subsequently displaying the products (peptides) at the surface where they can be recognized by T cells. If the peptide activates a cytotoxic T cell, the response by the T cell is to kill the infected cell, thereby preventing the infection from spreading. Activated helper T cells, in contrast, release factors that drive and guide B and cytotoxic T cell activation. Dr. Eisenlohr's dissertation work demonstrated how the cell exploits the infectious cycle of the virus in presenting virus-derived peptides.
In 1988 Dr. Eisenlohr went to the National Institutes of Health for postdoctoral training, this time studying antigen processing for presentation to cytotoxic T cells, with continued focus on influenza proteins. His studies provided important insights into how peptides are generated and also demonstrated that the foreign protein itself can strongly influence which peptides are presented. Interestingly, at that time the antigen processing pathway for cytotoxic T cell activation was thought to be very different from the pathway for helper T cell activation that Dr. Eisenlohr had studied in graduate school. Recently, however, the Eisenlohr lab and others have shown that the two pathways overlap much more extensively that originally thought, an insight that may fundamentally alter approaches to vaccine design, autoimmunity and cancer immunotherapy.
In 1992, Dr. Eisenlohr became an independent investigator at Thomas Jefferson University where he is now Professor of Microbiology and Immunology. The laboratory continues to investigate antigen processing pathways with virus-based systems and interests have expanded into studies of immunological memory and anti-cancer immunity. Dr. Eisenlohr's work has been funded by the National Institutes of Health, the American Cancer Society, and the Leukemia and Lymphoma Society. He is a reviewer for over 20 journals, is currently on the editorial board of Direct Biology/Immunology Section, and has recently joined the "Faculty of 1000", a selected group of investigators that identifies publications of special interest to the research community. He was selected as a Leukemia and Lymphoma Society Scholar in 1999 and in 2004 was named a L&LS Stohlman Scholar, an award that recognizes the achievements of five departing Scholars.
Dr. Eisenlohr has been actively involved in education since joining Jefferson, receiving the Medical Education Development Award in Microbiology in 1999 and the Dean's Citation for Significant Contributions to the Advancement of Education at Jefferson Medical College in 2006. He has taught the Medical College Students in the Medical Microbiology course and organized and taught many Ph.D. level courses in the College of Graduate Studies. He was the major architect of the GC550 course, Foundations in Biomedical Research that all Ph.D. candidates take in the fall of their first year. He is currently Director of the Microbiology Ph.D. program and co-director of Jefferson's MD/PhD program.
David Hilbert, Ph.D. '79
For the past 14 years I have integrated my disciplined approach to science with the business of effective drug development and corporate management. The expertise gained has afforded me an appreciation of the biotech environment and the experience to transform the many challenges within that environment into opportunities for success. Currently, I am an independent consultant assisting pharmaceutical companies with portfolio and strategic development. Previously, I was a member of the senior management team at Cellective Therapeutics, a start-up antibody company acquired by MedImmune in October 2005. Prior to Cellective, I was the Vice President, Research at Human Genome Sciences where I led a team of 125 dedicated scientists, research associates and support personnel responsible for discovery, target validation, antibody development, assay development, toxicology, pharmacokinetics, clinical testing and animal husbandry functions. Prior to HGS, I was a Staff Fellow in the National Cancer Institute, NIH. Throughout my career, I have published 45 peer-reviewed manuscripts and am an inventor on numerous patents.
Art Krieg '79
After Haverford I went to Med School and started off in internal medicine, with a special interest in immunology and autoimmunity because it seemed like such a wide open field. I loved taking care of patients, which I ended up doing for almost 20 years, but I decided during my internship that I really wanted to try academic medical research.
So I went to the NIH to do a 2-year rheumatology fellowship, and ended up staying for 5 years. While at NIH, I became interested in antisense technology, and became founding co-editor of the first the first antisense journal, and later co-founder of the Oligonucleotide Therapeutic Society.
My first academic position was at the University of Iowa in rheumatology, where I took care of patients, teaching medical and graduate students and, of course, doing basic research. In the course of my research I discovered that certain DNA sequences were extremely immune stimulatory because they "looked like" bacterial DNA to the immune system. The stimulatory element that I identified is called a "CpG motif" - cytosine-phosphate-guanosine (a C followed by a G).
Based on my CpG work , I founded a biotech company, Coley Pharmaceutical Group. The company became operational in 1998 and in 1999, with three employees, we started our 1st clinical trial to test if the addition of a synthetic oligonucleotide containing a CpG motif to a hepatitis B vaccine would improve the vaccine response, and it was a huge success. We had a statistically significant increase in antibody response, along with a dramatic acceleration in the speed of the response. Several vaccines using our CpG are now in development.
I left academia to join Coley full-time in 2001, and we went public in 2005. In 2007, we and our then-partner, Pfizer, had the unfortunate experience that the phase III clinical trials of our technology in metastatic lung cancer failed. Nevertheless, we had so much positive data using the technology in vaccines that Pfizer vaccines acquired Coley in 2008, at which time I decided to join Pfizer to continue to work on oligonucleotide drug development.
Barry Ticho '81
Barry Ticho, M.D., Ph.D., Vice President, Cardiopulmonary and Emerging Therapeutic Areas, has been with Biogen Idec for 9 years. He is responsible for oversight of ongoing clinical development programs in heart failure and inflammatory bowel disease indications. Dr. Ticho obtained his M.D. and Ph.D. degrees from the University of Chicago and completed Pediatric Cardiology training at Children's Hospital, Boston, MA. He currently maintains a position as an Assistant in Pediatrics at Massachusetts General Hospital. Dr. Ticho held a previous position in Clinical Pharmacology at Merck & Co
Dr. Benjamin Jacobs '81
Haverford College BS 1981; Wake Forest University School of Medicine 1985; Internship Hospital of St. Raphael (New Haven, CT) 1986; Anesthesiology residency Yale New Haven Hospital 1986-1989; Asst. Professor of Anesthesiology Yale U. School of Medicine 1989-1991; Private practice anesthesiologist 1991-present; Chairman of Anesthesia - Paoli Memorial Hospital 1993-1999; Chairman of Anesthesia - Main Line Health System 1997-1999; Director of Anesthesia - Paoli Surgery Center 1994-present
Ted Love, MD '81
Ted W. Love, M.D. was most recently Chairman and Chief Executive Officer of Nuvelo, Inc., a biopharmaceutical company, from March 2001 to January 2009, having been appointed President and Chief Operating Officer of Nuvelo in January 2001. He served as a director of that company since February 2001 and became Chairman of the board of directors in September 2005. He joined Nuvelo from Theravance, Inc., a biopharmaceutical company, where he served as Senior Vice President of Development from February 1998 to January 2001. Prior to that, he spent six years at Genentech, Inc., a biotechnology company, holding a number of senior management positions in medical affairs and product development. Dr. Love serves as a director of several companies including Affymax, Inc., Santarus Inc., ARCA Biopharma and KaloBios Inc. He also serves on the 29-member California Independent Citizen's Oversight Commission, which oversees the $3 billion allocated to stem cell research authorized by California Proposition 71. Dr. Love holds a B.A. in molecular biology from Haverford College and an M.D. from Yale Medical School. He completed his internal medicine and cardiovascular fellowship training at Massachusetts General Hospital and Harvard Medical School.
Dr. Stephen Devoto '82
I left Haverford with a burning passion to understand how cytolytic T lymphocytes recognize a target cell (haptenated spleen cells). After a year working as a lab technician, my interests in cell-cell recognition took the form of a Ph.D. thesis (Rockefeller University, 1989) on the interactions between a growth cone and a target cell. I studied how synapses form in the embryonic rat nervous system, working with Colin Barnstable (himself a former immunologist, he's now at Yale). My wife's career then pulled me to Duke, where I did postdoctoral work with Joseph Nevins at Duke on the relationship between cell cycle control proteins (cdc2, cyclin A, and Rb) and a transcription factor (E2F). In 1992 I returned to cell-cell signaling in a second postdoc, with Monte Westerfield at the University of Oregon. I worked on how cells in the early zebrafish embryo are fated to adopt the muscle fate, and how the fiber type identity of specific muscle fibers is determined. We demonstrated that signaling by the secreted protein, Hedgehog, regulates muscle differentiation. I have been on the faculty of Wesleyan University since 1997, and my research continues to be on muscle development and growth, and the mechanism by which those are regulated by Hedgehog signaling.
David Lewinsohn '82
Human Host Response to Tuberculosis
Department of Pulmonary & CCM PVAMC / OHSU
Tuberculosis is a leading single cause of infectious disease mortality worldwide. Immunity to tuberculosis depends upon the cellular immune system. Hence, developing an improved vaccine will require an understanding of the mechanisms by which T cells recognize cells infected with the bacterium Mycobacterium tuberculosis (Mtb). Because Mtb is a facultative intracellular pathogen, cytotoxic T cells may be important in the recognition and elimination of infected cells. My laboratory has used Mtb-infected peripheral blood derived dendritic cells (DC) to elicit human CD8+ T cells capable of lysing cells infected with Mtb. These T cells recognize antigen in the context of a "restricting molecule", so that understanding the nature of this restriction may aid in designing effective vaccine strategies. Recently, we have characterized CD8+ T cells that are restricted by the non-classical MHC molecule HLA-E. In order to define the relative contribution of each classical vs non-classical HLA restriction in the overall CD8+ response to Mtb, we have used an ELISPOT-based limiting dilution analysis. In several PPD+ subjects, the majority of the Mtb-specific CD8+ T cells were non-classically restricted, while a minority were classically HLA-restricted. Using T cell clones derived from this approach, areas under investigation in our laboratory include defining the molecular requirements for non classical antigen presentation, defining antigens recognized by Mtb-specific CD8+ T cells, and defining the pathway by which Mtb-derived proteins gain access to the HLA class I processing pathway. It is hoped that this work may aid development of an effective vaccine against tuberculosis.
Dr Adam Pallant '82
I am the Pediatric Residency Director at Hasbro Children's Hospital at Brown Medical School. I am interested in helping young physicians create a career that will help to make the world a better place for children, whether it be locally or globally, primary care or specialty, practical or research oriented.
Dr. Seth Kates, MD '83
1983 B.S. Biology, Haverford College
1988 M.D., University of PA
1989 Internship year Dartmouth Hitchcock Medical Center
1992 Residency in Dermatology, Hospital of the University of PA
1997 Chairman Dept of Dermatology Fallon Clinic
1997-present private practice Dermatology Worcester and Chelmsford, MA, specializing in general, surgical, and cosmetic dermatology
Dr Jonathan Reeser '83
Upon graduating from Haverford with my degree in Biology (I worked with Mel Santer as a senior), I deferred my admission to The Ohio State University College of Medicine in order to send a year teaching algebra and computer programming at an American-curriculum secondary school outside of London, England.
I returned to the USA in late summer 1984, married Nandita Bhattacharjee (BMC '83), and started medical school at Ohio State. Due to some health problems I was forced to withdraw from my second year of medical school. In order to put my time to good use I enrolled in the Graduate School, and eventually decided to pursue a doctorate in cell biology in addition to the MD. I graduated with my PhD in 1991 and my MD in 1993, then began my residency training in Physical Medicine and Rehabilitation at Ohio State. Four years later I was ready to begin my clinical practice, as was Nandita (who was just finishing up her fellowship in Abdominal Imaging at OSU - having earlier earned her Masters in Health Administration and her MD from Ohio State).
Our job search led us to Marshfield Clinic in Marshfield, Wisconsin. Marshfield Clinic is a large (700+ physician) multispeciality practice that serves central, western, and northern Wisconsin. After a few years I was elected chair of the PM&R department. During this time I held leadership positions as chair of sports medicine for USA Volleyball, in addition to serving as a member of the medical commission of the International Volleyball Federation. I was also engaged in a handful of clinically oriented research projects during this period.
I retired from clinical medicine in 2006 due to progression of the early onset Parkinson's Disease with which I was diagnosed in 1999. Since then, I have been working in an administrative role for the Marshfield Clinic Research Foundation, as chair of both the Institutional Review Board (a position to which I was initially appointed in 2004) and the Research Committee (since 2007). I continue to maintain a small eclectic research program, recently completing two projects examining risk factors for shoulder problems among volleyball athletes, in addition to a study investigating whether Apolipoprotein E4 is a risk factor for the fibromyalgia syndrome.
Even before reading President Emerson's recent essay on the importance of a liberal arts education in producing "stem cells", I have long maintained the importance of professional pluripotency (i.e. the ability to competently perform in several different arenas if necessary). My career is a testimony to the advantages offered by such an approach, and I have no doubt that Haverford helped to lay the foundation that enabled me to pursue such a varied and interesting path.
Nandita and I live in Marshfield with our two sons (ages 15 and 8), and a daft but highly affectionate English Cocker Spaniel named Charlie.
Dr Geoffrey Tombaugh '84
PhD Stanford Univ. 1986-1991; Post doc, Duke Univ. 1992-1998; Sr. Staff Scientist, Memory Pharmaceuticals 1998-2008; Principal Scientist, Psychogenics 2009-present
Wayde Weston, PhD '84
1980-1984 - Haverford College, BA (Biology)
1984-1990 - University of Pennsylvania, PhD (Biology)
1989-1997 - Thomas Jefferson University, Philadelphia PA - Postdoctoral fellow and Research assistant professor, Department of Anatomy - Research focusing on cellular and molecular mechanisms of mammalian craniofacial development
1997-present - GlaxoSmithKline, King of Prussia, PA - Clinical research and development for cardiovascular and metabolic drug development and vaccine development
Ron Laby '85
After Haverford I worked for 2 years as a research associate at Biogen, Inc. (transgene expression, mammalian cell culture) and then started graduate school. I received M.S. & Ph.D. degrees in Plant Pathology at Cornell Univ., studying mechanisms of bacterial virulence and pathogenicity in plants.
Subsequently I worked as postdoc at Rice Univ., studying the molecular genetics of sugar- and plant hormone- signaling in Arabidopsis plants. For the last ~10 years I have been a Patent Agent at several law firms, assisting with patent prosecution (obtaining patents) and patent litigation support in the areas of medical and agricultural biotechnology.
Dr Peter Margolis '86
Currently (2006-present) working as consultant/contract medical and technical writer for multiple pharmaceutical and biotechnology companies, CROs, and academia, including government grant applications and pre-clinical efficacy, toxicology, pharmacology, and histopathology protocols, proposals, and study reports.
Previously (1998-2005) employed as drug discovery biologist at Vicuron Pharmaceuticals (formerly Versicor), Inc., a biotechnology start-up (subsequently acquired by Pfizer) that was devoted to R&D of novel antibiotics for use in the hospital setting. Identified and validated novel anti-bacterial and anti-fungal drugs and drug targets, using genetic, molecular, and bioinformatic tools. Designed and implemented new in vivo and in vitro assays for testing antibiotic efficacy, toxicology, and pharmacology. Post-Haverford training included a PhD at Harvard University (1986-1993) in the laboratory of R. Losick, Dept. of Molecular and Cellular Biology; and a post-doctoral fellowship (1993-1998) at Stanford University in the laboratory of C. Yanofsky, Dept. of Biology.
Chuck Sabino '86
1986-1987 Lab Technician, The Wistar Institute; 1987-1989 Pharmaceutical Sales Representatitve, Pfizer Inc.; 1989-1991 MBA, Columbia Business School; 1991-2001 Market Research and Marketing positions at Pfizer Inc.; 2001-2007 Executive Director, Marketing and Sales at Novartis Pharmaceuticals; 2007-2009 Managing Director, CDM advertising and consulting agency; 2009-present Chief Operating Officer at Lipose Corp. (small medical device start-up)
Dr. Katherine Nathanson '87
Dr. Nathanson received her BA in Biologyfrom Haverford College and her MD degree from the Penn Medicine. She completed housestaff training in Internal Medicine at the Beth Israel Hospital, Boston and in 1996 was selected as a Chief Resident in Medicine at the West Roxbury VA Hospital. She then returned to Philadelphia and completed a fellowship in Genetics at the Children's Hospital of Philadelphia and the Hospital of the University of Pennsylvania from 1996-2000. Dr. Nathanson was boarded in both Internal Medicine and Medical Genetics and is one of very few individuals in the country trained and board certified in both specialties. She currently is an Assistant Professor of Medicine.
Dr. Nathanson is a physician-scientist whose research and clinical practice are in the field of cancer genetics, with the ultimate goal of using genetics as a tool to improve the management and care of patients. Her primary commitment is leading a research program focused on both inherited and somatic genetics of cancer. As her research focuses on the translation of our understanding of cancer genetics into clinical care, she collaborates with faculty members in many different disciplines within the institution and outside, including among others basic scientists, phase 1 clinical trialists (oncologists), pathologists and epidemiologists. With her training and knowledge, she is able to participate in and facilitate collaborations between these different groups. Currently, the principal areas of her research, described in detail below, are 1) Susceptibility to Testicular Germ Cell Tumors (TGCT); 2) Somatic Genetics of Melanoma; 3) Hereditary Breast and Ovarian Cancer and 4) Renal Cancer Genetics.
Dr Michael Goretsky '87
Associate Professor of Surgery and Pediatrics at Eastern Virginia Medical School
Pediatric Surgeon at Children's Hospital of the Kings Daughters
Dr. Diana Curran-Galejs '87
I wasn't sure what I wanted to do after Haverford. I went to medical school and love being an obstetrician gynecologist. I still use what I learned being a biology major at Haverford every day in my practice and when teaching. I am teaching at Univ Michigan now and have a private practice, as well. The great thing about medicine is you can morph into all kinds of things. I started out in private practice and realized I missed teaching. Now I spend time designing new curricula for residents to improve graduate medical education.
Dr Erik Lamberth '88
After Haverford, I attended the Berklee College of Music and studied guitar and Music Production. I discovered that I really did not enjoy the business side of music, and taught biology at the Friends' Central School before entering Temple University School of Medicine. After medical school and residency at St. Christopher's Hospital for Children, I began practicing Pediatrics at Pennridge Pediatrics. I am active in vaccine research, and have participated in numerous vaccine trials including principal investigator at our site for the Menactra, TdaP, Flumist, and Lyme booster trials. I also chair the IRB at Grand View Hospital and we oversee 35-40 clinical trials at one time in Cardiology, Oncology, and Pediatrics as well as trials from the NIH and Unniversity of Pennsylvania. I have also had the opportunity in recent years to be a guest speaker and teach a course on vaccine development at Haverford.
Ander Pindzola '89
Currently (and hopefully for many years to come) I am practicing general pathology at York Hospital in south central PA, about 45 minutes north of Baltimore and 90 minutes west of Haverford. York Hospital is a large, teaching, community based hospital. Following graduation from HC in '89 I went to medical school at Jefferson in Philly and stayed on at Jefferson for my 5 years of general (Anatomic and Clinical) pathology residency. I spent 2 more years in subspecialty training at the University of Pittsburgh Medical Center studying hematopathology (leukemias and lymphomas, etc).
I've been at York for 8 years and it is a wonderful place to work! Primarily I spend my time at the microscope reading slides from a broad variety of anatomic sources. I act as a consultant in my group for anything pertaining to hematopathology and I provide oversight to the hematology lab, immunohistochemistry lab and serve as vice chair of the department.
My Biology training at HC prepared me extremely well for my career, even though when I graduated I didn't even know what a pathologist was! I'd love to speak to any HC students potentially interested in Pathology as a career.
Mr. Kurt Calia '90
I am a partner in the Washington, DC office of Covington & Burling LLP, practicing in the areas of complex civil litigation, patent litigation, intellectual property, life sciences, and patent prosecution. He is a former co-chair of the firm's Patent Group. His practice focuses largely on the firm's high technology clients in a wide range of areas including pharmaceutical chemistry, agricultural biotechnology, biomedical devices, mechanical devices, business methods, microprocessors, and software. I have significant trial experience, having most recently appeared as patent trial counsel for a J&J subsidiary concerning an Alzheimer's disease drug, and having previously participated in a series of intellectual property trials for Monsanto concerning genetically modified crops. I also have a background in prosecuting and defending trade secrets cases, particularly arising in the context of complex litigation involving other intellectual property claims.
After graduating from Haverford, I attended the Boston University School of Law (J.D. 1993) and practiced at Howson & Howson in the Philadelphia area before joining Covington in 1995.
Laura Herndon, PhD '91
1997 PhD in Genetics and Developmental Biology from Cornell University
1997-2005 Postdoc with Dr. Monica Driscoll at Rutgers University studying the biology of aging in C. elegans
Herndon L.A. et al.: 2002. Stochastic and genetic factors influence tissue-specific decline in ageing C. elegans. Nature 419: 808-814.
2005-present Work with Dr. David Hall at Albert Einstein College of Medicine as a Writer/Editor/Webdesigner for WormAtlas.
Dr. David Kim '91
1991 - 1992: Teacher, American School of the Hague, The Hague, Netherlands. ES/MS/HS computer science, HS biology, adult ed photography.
1992 - 1997: Biologist, National Institutes of Health, National Institute of Dental and Craniofacial Research (formerly, National Institute of Dental Research), Bethesda, Maryland.
1997 - 2001: Dental School, Boston University.
2001 - 2002: Fellowship, Oral and Maxillofacial Surgery.
2002 - 2004: Private Practice, Rutland, Vermont.
2004 - present: Private Practice, Lawrenceville, NJ. Restorative and Implant Dentistry.
Dr. Jean-Luc Jannink '91
M.S. in Plant Science
Ph.D. in Plant Breeding with minor in Sustainable Agriculture
I work now as a statistical geneticist developing statistical methods that take advantage of large amounts of genetic data to accelerate crop improvement.
Mr. Daniel Braz '93
I have worked as an entrepreneur in both healthcare and technology startups; a mergers & acquisitions generalist investment banker at Merrill Lynch and cross-border M&A boutique Fredericks Michael & Co.; a senior health care and hospital administrator at Beth Israel Medical Center in New York; a life sciences venture capitalist at CrossBow Ventures; and a management consultant at PricewaterhouseCoopers.
Most recently, I was the President and COO of a leading provider of integrative healthcare services, WELLSPACE, featured in the White House Commission for Complementary & Alternative Medicine. I led the Company's growth from one location to four in less than two years; spearheaded Company's successful seed, angel round and Series A fundraising campaigns; discussed improvements to healthcare systems of Dubai and Bahrain, on invitation by the Ambassador of Bahrain to the United States; and was a guest lecturer at Harvard Business School.
Last year I rejoined Fredericks Michael & Co. in New York where I advise corporations, family owned businesses and private equity groups on "cross-border" mergers & acquisitions transactions (i.e., acquisitions and/or sales of businesses that usually involve parties based in different countries).
Dr Alison Volpe Holmes, MD, MPH '93
I am an academic general pediatrician at a community hospital in central New Hampshire. We are a Dartmouth Medical School teaching site. I teach medical students and residents in clinical inpatient pediatrics. After 3 years of bench research after Haverford, I attended medical school at Stanford, graduating in 2000. I then completed a pediatrics internship and residency at the University of North Carolina at Chapel Hill, and a fellowship in academic general pediatric and a Masters in Public Heatlh at the University of Rochester School of Medicine and Dentistry. I wish I had known about public health and population-based research while I was an undergraduate. I currently do research in a number of clincial areas and in medical education, with special interests in breastfeeding, underserved and rural populations, and pediatric hospital medicine.
Dr. Ida Fox '94
I am a plastic surgeon at Washington University School of Medicine/Barnes Jewish Hospital. I do mainly adult reconstructive surgery including hand, peripheral nerve, breast reconstruction and other surgeries.
Dr. Daniel Noland '94
Haverford BS 1994 (Take the BS you can't work in a lab with a BA!)
MD: UNC-Chapel Hill 1998; Family Practice Residency 2001; Medical Informatics 2003; Pathology Residency 2007; Transfusion Medicine Fellowship 2008; Assistant Professor of Pathology UTSW/Children's Dallas
Dr Justin Annes '96
Haverford Class of 1996; NYU School of Medicine MD/PhD completed 2004; Harvard Medical School/Brigham and Women's Hospital Residency/fellowship Internal Medicine and Clinical Genetics
Harvard Medical School Instructor in Internal Medicine
- Attending in Department of Internal Medicine, Division of Genetics at Brigham and Women's Hospital
Research Fellow in the Harvard Department of Stem Cell and Regenerative Biology
- Laboratory of Douglas Melton (very receptive to summer interns)
- Research interests- Regenrative Biology and Diabetes
Riccardo Magni '96
I have been teaching high school Biology in California for 13 years. Currently I am the Science Department Head at my school, as well as BTSA mentor, Varsity Track coach, and library tutor.
I also have gotten my Master's Degree in Education. I am a professor for Chapman University in their Education Department.
I would be interested in helping Haverfordians interested in teaching science in high school if I can.
Hannah Bayer, PhD '96
I received my PhD in neuroscience from New York University, where I studied the role of the basal ganglia in reinforcement learning with Paul Glimcher. I then moved to a postdoctoral fellowship at Columbia University where I investigated neural representations of risk perception and risky choice with Elke Weber. I am currently an associate editor at the journal Nature Neuroscience.
Dr. Carolyn Weber '96
After graduating from Haverford, I worked in Jennifer Punt's lab at Haverford for a year while I applied to medical school. I attended the University of Pittsburgh School of Medicine and then I completed my residency in pediatrics at Columbus Children's Hospital. I took almost a year off from working after I had my older daughter, then I started working part-time at South Jersey Pediatric Associates, a private pediatric practice in Cherry Hill, New Jersey.
Peter Clapp '97
After graduating from Haverford in 1997, I was awarded a pre-doctoral fellowship at the National Institute of Diabetes, Digestive and Kidney diseases (NIDDK) in Bethesda, MD where I studied post-translational modifications to the calcium-sensing receptor with Dr. Allen Spiegel. This began a long tenure of work on G-proteins and G-protein coupled receptors that would continue through graduate school. I matriculated at the University of Michigan in the Biochemistry department and began studying G-protein regulation of adenylyl cyclase enzymes with Dr. Ron Taussig. When Ron returned to UT-Southwestern to work with his former mentor, I remained in Ann Arbor and initiated a project on novel scaffold proteins for alpha-adrenergic receptors with Dr. Rick Neubig. After earning a Ph.D. from Michigan, I came to the University of Colorado to investigate the role of NMDA receptors (which are not G-protein coupled!) in the development of tolerance to alcohol with Dr. Paula Hoffman. I am continuing this research while teaching Biochemistry in an adjunct capacity at the Red Rocks Community College and seeking a tenure-track position at a small college in the region.
Dr David Zobian '98
Biology major, 1998. Karl Johnson was my thesis advisor (a proud Chlamy alum, am I)
1998 to 1999 National Institutes of Health, Bethesda, MD
Pre-IRTA fellow, Dr. Michael Beaven, NHLBI: Constructed viral plasmids containing a possible phospholipase D regulatory
domain. Infected rat basophil lymphoma cells with Simliki Forest Virus carrying
the plasmid and performed stimulation response experiments to characterize the
function of the domain.
1999 to 2000 Habitat for Humanity, North Philadelphia
Taught and led volunteers in drywalling, siding, and roofing. Honed managerial
and organizational skills.
2000 to 2004 Temple University School of Medicine, Philadelphia,PA
Residency: 06 / 2004 to 06 / 2006 DuPont Hospital for Children, Thomas Jefferson University Hospital
Pediatric residency, PL-1 and PL-2 years in Wilmington, DE and Philadelphia, PA
07 / 2006 to 12 / 2007 Penn State Univ. School of Medicine, Hershey Medical Center
Pediatric residency, PL-3 year in Hershey, PA
Pediatric Work Experience
01 / 2008 to present - All About Children Pediatric Partners in Reading, PA
General Pediatrician, inpatient and outpatient care, medical staff at both Reading Hospital and St. Joseph Hospital
Dr. Jaimie Goralnick '98
After college I spent a year with Americorps VISTA working on an inner city violence prevention project in Philadephia. I then attended medical school at UMDNJ-RWJ in Piscataway and Camden, NJ, graduating in 2003. I completed a psychiatry residency at Baylor College of Medicine in Houston in 2006, then moved to NYC for my child and adolescent psychiatry fellowship at New York Presbyterian Hospital. Since graduating in 2008 I have worked as a child psychiatrist for Visiting Nurse Services (VNS) at their childrens mental health clinic in the South Bronx and I started a private practice on the Upper East Side.
Whitney Brimfield '98
I have worked for the past 10 years in both the non-profit and for-profit sectors on health-related issues. In 2004 I receieved a Master of Health Science in Health Communications from Johns Hopkins Bloomberg School of Public Health. I am currently the Development Director for the National Assembly on School-Based Health Care.
Dr Ntobeko Ntusi '98
Since graduating from Haverford College, I have attended medical school in South Africa. After qualifying from medical school, I embarked on a fellowship in Internal Medicine and Cardiology. Am currently finishing an MD in Clinical Cardiology. Will be doing a D.Phil at Oxford University, commencing in the fall. Would be very happy to host Haverford students interested in clinical medicine or cardiac magnetic resonance imaging.
Dr Laurie Prober '00
After graduating from Haverford, I went on to the University of Pennsylvania School of Veterinary Medicine, from which I graduated as a small animal major in 2004. I completed a small animal rotating medicine and surgery internship at Red Bank Veterinary Hospital (New Jersey) in 2005. In July of 2008, I finished my residency in Small Animal Internal Medicine at Michigan State University. This specialty focuses on gastrointestinal, renal, hepatobiliary, pancreatitic, endocrine, hematologic, respiratory, urogenital, immune-mediated, neurologic, oncologic, and infectious diseases. In general, patients are referred to internal medicine specialists from general practice veterinarians when the patient's disease is complex either in terms of the diagnostic or treatment plan.
I currently work at the Veterinary Specialists of Rochester in Rochester, NY. This multi-specialty hospital includes specialists in surgery, oncology, ophthalmology, critical care, radiology, cardiology, and internal medicine. We also have the only 24 hour emergency hospital in Rochester, NY (Animal Emergency Services). Our association of veterinarians includes 12 general practice veterinary hospitals throughout the Rochester region. Teaching new veterinarians is important to me and I am very involved with the internship program at our hospital. We offer further training for rotating and specialty interns as well as surgery residents.
Dr Kathryn (Brinner) Brigham '00
After graduating from Haverford in 2000, I attended Harvard Medical School, graduating in 2004. I completed my pediatric residency at Massachusetts General Hospital in 2007, which was followed by a year as chief resident in pediatrics, also as MGH. I am currently in the midst of a 3 year fellowship in Adolescent/Young Adult Medicine at Children's Hospital Boston.
Lauren Giarratani '00
For the last 4 years I have been working with an education research group at the University of Pittsburgh that studies learning in out-of-school settings. I support research that qualitatively and quantitatively examines science and technology learning. My roles include educational program development and implementation, designing and coordinating research studies, forming and maintaining partnerships between University researchers, community groups, and informal learning institutions. My most significant projects at have been:
- In Robot 250, an initiative to engage Pittsburgh with robotics, I worked with CMU researchers and community partners to develop robotics workshops for middle school students. Research around these programs examines students' creative uses of technology.
- At the Carnegie Museum of Natural History, I helped design and evaluate programming for general visitors and middle school groups in the Fisher Scientific Biotechnology Lab.
- In the Click! Urban Adventure, a game designed to engage middle school girls with science, I helped coordinate and evaluate science content and was part of the instructional team. Research examined girls' experiences learning about science and technology through collaboration, inquiry, and role play.
I recently completed my PA teaching certifications for Biology & General Science, grades 7-12. Hopefully in fall 2009 I will be teaching science to young people in Pittsburgh.
Prior to working in Pittsburgh, I was a research assistant in Fred Alt's immunology lab at Children's Hospital in Boston, and I was a graduate student in Leslie Vosshall's lab of neurogenetics & behavior at Rockefeller University in New York. I have also served on the Board of Directors for Student Pugwash USA, an educational organization concerned with how science, technology and society influence one another.
Dr. Steven Quatela '01
After graduating from Haverford in 2001 with a Bachelor of Science in Biology with an Area of Concentration in Biochemistry, I began studying at New York University School of Medicine in the Medical Scientist Training Program (MSTP) pursuing the combined M.D. and Ph.D. degrees. After completing my first two years of medical school, I went on to my doctoral thesis work involving the K-Ras oncogene in the laboratory of Mark R. Philips, M.D., and published my findings that "Protein Kinase C (PKC) Regulates a Farnesyl-Electrostatic Switch on K-Ras that Promotes its Association with Bcl-XL on Mitochondria and Induces Apoptosis." In brief, we discovered a novel method of regulation of K-Ras by phosphorylation which had the surprising result of inducing cell death, rather than growth or proliferation as might be expected for an oncogene. The eventual hope is to discover a way to harness this so-called "farnesyl-electrostatic switch" to induce cell death in human cancers dependent on K-Ras for their tumorigenic potential. I successfully defended my thesis in 2007 and received the Doctor of Philosophy (Ph.D.) degree in Basic Medical Sciences that same year. I returned to the hospital wards to complete my third and fourth year medical clerkships, and received the Doctor of Medicine (M.D.) degree in May 2009. I will be starting my residency in the Department of Pediatrics at the New York Presbyterian-Weill Cornell Medical Center in July 2009, and hope to eventually complete a Fellowship in Pediatric Hematology/Oncology.
Dr John Szumowski '02
2002-2007 MD, Harvard Medical School; 2006-2007 MPH, Harvard School of Public Health; 2007-present Resident, Department of Internal Medicine, Beth Israel Deaconess Medical Center (Boston, MA)
Current plans: Fellowship in Infectious Diseases (2010)
Clinical and Research interests:
HIV/AIDS, International Health, Community-acquired Methicillin-resistant Staphylococcus Aureus
Dr. Ronald Bossert '02
While at Haverford I worked in Dr. Judy Owen's lab, my thesis on various IAPs and their role in regulating apoptosis in CD4 cells. After graduating in 2002 I matriculated to the University of Rochester School of Medicine and graduated with my MD in 2006. At that time I accepted a residency position in Plastic Surgery at the University of Rochester Medical Center and am about to enter my fourth year of residency training.
Ms Jill Garland '02
I teach 4th and 5th grade at The Philadelphia School, an independent preK-8 progressive school in Center City Philadelphia.
Dr. Sara (Rybolt) Caruso '02
Upon graduating from the University of Pennsylvania School of Veterinary Medicine in 2006, I joined a small animal veterinary practice in Colchester, Connecticut. I continue to practice as an Associate Veterinarian at the Colchester Veterinary Hospital. The veterinary hospital treats cats and dogs and has 10 veterinarians.
Caitlin Kight '03
After graduating from Haverford College in 2003, I worked as an intern for the US Fish and Wildlife Service at the Blackwater National Wildlife Refuge. The following fall, I enrolled at the College of William and Mary, where I received an MS studying the effects of human disturbance on the breeding success of eastern bluebirds. In the fall of 2005, I began work on my doctorate in William & Mary's applied science department; I continued my work on human disturbance and eastern bluebirds, but broadened my interests to include sound and habitat disturbance and their impacts on avian communication and mating success. I am currently in the last year of my doctorate and hope to defend in December. Throughout my time as a graduate student, I have also pursued my interest in communicating science to a non-scientific audience; to this end, I have published articles in nature and birding magazines and given talks at local libraries and bird clubs.
Ms. Rachel Leaversuch '03
I am a high school biology and environmental science teacher in Massachusetts.
Elizabeth Hansen '03
I have been a consultant in Boston at a strategy consulting firm in the Healthcare and Pharmaceuticals practice for about four years. I speak with people in the industry and do primary and secondary research on diseases and business issues for clients, who are primarily in the pharmaceutical or medical devices space. I frequently go to medical conferences as well and speak with paper authors, etc, in addition to practicing physicians and PhDs presenting their research. In the end, I help organizations improve their strategies for the medications and devices in the market.
Before this I worked with a healthcare market research firm that where I coauthored two 300+ page reports on the current state of two specific diseases. Within that, I frequently had to interpret data from academic papers and regularly interviewed practicing physicians in the G7 (US, Japan, Italy, Germany, France, England, and Spain) to find out what they were seeing in the practice and what their unmet needs were for diagnosis and medication. In addition, I used certain pricing models to predict medication pricing in the US, EU, adn Japan.
Directly out of school, I did cancer research on p53 in the lab of Zhi-Min Yuan at the Harvard School of Public Health. I am a coauthor in the paper "Modulation of p53 and MDM2 activity by novel interaction with Ras-GAP binding proteins," published in the June 2007 issue of Oncogene.
The summer right after I graduated I was a curriculum designer for a summer education institute where I designed the curriculum for two fourth grade summer science classes - one on Germ Biology and one on Astrobiology.
I loved Haverford and I would be very happy to help current Haverford biology students. I also have a minor degree in economics from Bryn Mawr.
Mr. Brandon Johnson, MD '04
After graduating from Penn Medical School in 2008, I am currently finishing a preliminary internship year at the Hospital of the University of Pennsylvania in the department of General Surgery. I will begin my residency in Ophthalmology at Wills Eye Institute with Jefferson July 2009.
Ebony Washington '04
I am a 4th year PhD student at Emory University in Atlanta, GA in the department of Biochemistry, Cell and Developmental Biology. My lab is in the department of Cardiology where I study the pathogenesis of Abdominal Aortic Aneurysms. Our lab also investigates atherosclerosis, diabetes and the involvement of reactive oxygen species (ROS) in heart disease. We have a large lab composed of graduate students, post docs, technicians, medical fellows and interns and volunteers at various stages in education ranging from high school to post baccalaureate.
Josh Havassy '04
Since Haverford, I've had a few jobs... I worked on AIDS prophylaxis in a small biotech lab for a while in 2005, I did some consulting work for a small computer programming company that built compensation systems at large corporations, and recently, I worked at a non-profit organization in Philly doing development work and grant writing. But throughout the past 5 years, even during stints at the other jobs, I've been a rehab counselor at the Renfrew Center, an eating disorder treatment center.
Renfrew is the first and large inpatient eating disorder treatment center in the country. The patients are women over 14 years old. As a counselor, I spend all day with the patients, eat meals with them, run groups, have one-on-one sessions, advise the treatment teams, and generally just be whatever the patients need as they move through treatment. Over the years, I've learned a lot about eating disorders and psych, but also simply about the human condition, social interaction, and the links between behaviors and thoughts. It's a taxing but rewarding job and I would encourage anyone interested in working with and learning about/from people to consider a job in the rehabilitation world. At Renfrew, I also do some work in the utilization review department wrestling with insurance companies to get the most appropriate coverage for each patient.
Most recently, I'm mid-way through the Master of Public Health program at Penn and have not yet decided what I'm going to do once I graduate next year.
Dr. Jacob Bilhartz '04
After Haverford, I moved back to Dallas for medical school at the University of Texas Southwestern Medical Center. I graduated from UT Southwestern in 2008 and am currently in Ann Arbor, Michigan for my residency in pediatrics at the UofM Medical Center. Plans for the future include fellowship training in Pediatric Gastroenterology, and a possible move back to somewhere with a winter that doesn't last six months!
Ms. Michelle Bernardini '04
After four years in the lab of Dr. John Monroe studying the role of ITAM containing proteins in the transformation of mammary epithelial cells, I left Penn in 2008 for MIT-Sloan, where I am currently pursuing an MBA. My transition from science to business has been more natural than expected and I am enjoying seeing what opportunities are arising out of this experience. So far I have been completely suprised. This summer I will be interning at DHL in Southern Florida working in their internal logistics consulting group! Quite different from the work I was doing with Chlamydomonas in Karl's lab. I would be more than happy to discuss this alternative route with any current Fords who are thinking beyond the MD or PhD.
Susannah Locke '05
Susannah F. Locke is an editor at Popular Science magazine. She studied molecular bio and psych and ran the literary magazine at Haverford. Then she played with neurons as a research technician at the University of Pennsylvania and The Children's Hospital of Philadelphia for two years. After using almost every type of test tube on the market for every conceivable purpose, she removed her gloves to become a journalist and improve the public's understanding of science. She switched careers via a masters in science journalism from New York University. You can read her work in Popular Science, Discover, and Scientific American.
Nate Favini '05
2008-Present; M.D. Candidate, Harvard Medical School, Class of 2012
2005-2007; Peace Corps Volunteer/Secondary School Teacher (Biology), Nametil, Mozambique
Jessica Kuhn '06
I found a job in textbook publishing the summer after I graduated from Haverford. I moved out to San Francisco and was the Editorial Assistant for the Biology group. In this position, I coordinated and managed reviews of biology texts and generally supported the team of authors, internal and external customers, sales force, and the editorial team. I was in that position for 8 months before I was promoted to Assistant Editor for the Biology group as well. In this position I managed biology textbook supplements by hiring and guiding authors, as well as ensuring projects are within budgetary and time constraints. Then, I was in that position for 10 months before I was promoted to Associate Technology Project Manager for the Physics and Math group. In this position I managed all aspects of electronic and Internet-based supplements including budgeting, scheduling, planning content by evaluating market research, and creating a team of outside vendors. 5 months later, I found out that I had to move back East. When I returned to the Philly area, I continued to work in this position for another 2 months.
Now, I'm working at a multimedia and communications company based out of the UK. We work exclusively with GSK as their preferred vendor. I'm currently researching getting my Master's in Nutrition and getting my RD to become a practicing dietitian.
Laura Byrne '06
I am finishing my first year of medical school at the University of California, San Francisco. I took two years off before medical school, working in an immunology research lab for a year and then doing AmeriCorps in a community health clinic. I would be happy to talk about the benefits of taking time off before graduate school and how my experiences helped shape my later career plans. I'd also love to convince anyone to come to UCSF!
Ms Leah Gold '06
My biology degree at Haverford College has served me well in jobs that I have had since graduating in 2006. I have done research at Johns Hopkins University Hospital, and had a paper published in the journal Neurology. In addition, I was a Haverford House Fellow from 2006-2007 and worked at two non-profits. Since then, I have taught in Baltimore, MD and San Francisco, CA - high school physics, 7th grade life sciences, and 1st grade.
I am currently going to nursing school in Boston, MA, and will receive my BSN in December. My plans are to move back to California and work as an RN on a med/surg floor with a focus in psych nursing, and eventually go back to school to get an MPH. Although, what the past has taught me is that plans change, and now is the time to be exploring career choices, places to live, and discovering what I enjoy most.
Ms. Mary Anderson '06
BS in Biology from Haverford 2006
MS in Ecology from the University of California, Irvine (Class of '09) - focus on tropical rain forest restoration in Costa Rica
Co-founder of a nonprofit organization dedicated to providing global climate change education to K-8 students, with an emphasis on engagement with the problems and empowerment to act positively
Teach for America - high school life science teacher ('09-'11) in an underserved community in Eastern North Carolina
Ms Nina George '06
Currently in medical school at Philadelphia College of Osteopathic Medicine (PCOM), entering into my last year.
Melanie Smith '06
I'm currently in the MSTP (MD/PhD program) at the University of California San Francisco. My PhD is in biophysics with a focus on protein folding and interactions.
Mr Angad Singh '07
Joined McKinsey & Company after graduation
Miss Amy Arundale '07
I took a long time to decide whether I wanted to go to medical school and become an MD or get a doctorate in physical therapy and become a PT. It wasn't really until my senior year that I made a final decision that I didn't want to be an MD. Thus, I took a year off to take some time away from school and see the world as well as take some additional prerequisites. I spent a year as the William Penn Fellow teaching at the Chigwell School in London. I am now a student in the Doctorate of Physical Therapy program at Duke University.
Ms. Katherine Chiappinelli '07
Kate Chiappinelli is a second year doctoral student in the Developmental Biology Program at Washington University Medical School in St. Louis. She is doing her thesis work on epigenetic and transcriptional regulation in endometrial cancer, in the laboratory of Dr. Paul Goodfellow, Ph.D.
Sarah Freilich '07
I worked as a research assistant at UPENN School of Medicine in Dr. DiNardo's lab for 2 years and am now moving to Palo Alto to attend Stanford for a Masters of Arts to become a biology teacher.
Betty Tsang '07
After graduating with a B.S. in Biology, concentrating in Biochemistry, I took some time off from science to explore the world of business administration. I gained about a year of valuable experience as an office manager, helping to keep a small, private preschool in Philadelphia running smoothly. Before long, I knew I wanted to be in science again, so I looked into graduate school, postbaccalaureate programs, as well as employment in basic or clinical research. It can be a huge and daunting process, but I had a lot of informal conversations with as many people in relevant fields as possible, and before long, I found my way to what I wanted to do.
Currently, I'm working at the Department of Microbiology and Molecular Genetics at the Graduate College of the University of Vermont. I am investigating the activity of human enzymes in the repair of oxidative DNA damages in nucleosomes reconstituted in vitro, towards learning about how the cells in our bodies deal with these potentially mutagenic or apoptogenic events. Basically, I love it here and I'm extremely happy to have a job that allows me to use my own hands to create knowledge within a field of science that has for long held my deepest academic interests.
Linden Elder '08
I currently work for HealthCorps, a non-profit dedicated to combating childhood obesity and promoting healthy living through nutrition, fitness, and mental resiliency education in high schools across the country. On any given day I may be teaching Think Before You Drink, a lesson about the sugar content and benefits/risks of all kinds of popular beverages, hosting a Cooking Club after school, mentoring students with questions about sexual health, planning a city-wide health fair, or writing a weekly newsletter for my staff. I am generally known in my school as the "Health Lady"!
HealthCorps offers a great way to explore the worlds of public health, nutrition, education, social service, and event planning. Based on the Peace Corps model, HealthCorps serves as a launch pad for careers in medicine, research, public policy, public health, education, and beyond.
Tovah Tripp '08
After graduation, I worked as a lab technician for a year at the UPenn School of Medicine in the Department of Cell and Developmental Biology. In the fall of 2009, I will begin medical school at Robert Wood Johnson Medical School in New Brunswick, NJ.
Emily Hinchcliff '08
I graduated in 2008 after doing my thesis work in Jenni Punt's lab on microtubule polarization in thymocytes. Since graduation, I have been teaching Biology to highschool students in London, as a William Penn Fellow. Next year, I will be attending Harvard Medical School.
Miss Jayme Hopkins '08
I graduated from Haverford College in 2008 with a Bachelor of Science in Biology. I secured a job at The Children's Hospital of Philadelphia in the Human Embryonic Stem Cell Core Facility as a Research Assistant to Deborah French, Ph.D. (Director of CHOP HES Cell Core Facility). During my time here, I have not only maintained various ES cell lines, but I have also differentiated them into various cell types, including platelets, red blood cells, cardiomyocytes, monocytes, and liver. Knowing what genes to turn on/off and when to turn them on/off to drive one cell fate over another can be tricky, but with the appropriate experimental conditions, it can be done. Such research can be beneficial for future applications in regenerative medicine in hopes of treating various blood and liver diseases, and hopefully transplantation.
I intend on attending graduate school and obtaining a Ph.D. in Developmental Biology, hopefully in the Fall 2010! I am currently looking into different graduate programs in the area and preparing for my GRE examinations. I am so happy that I took a break between college and graduate school; not only was I able to sit back and take an academic breather, but I also got a taste of what being an adult is all about which is something I'm glad I learned now and not later.